For molecules excluded from oral development, this review has surveyed realistic alternatives that deserve systematic consideration: pulmonary delivery for rapid-onset needs, nasal delivery for rescue applications, buccal/sublingual delivery for potent peptides accommodating variability, and most importantly, long-acting injectables, depots, implants, and pumps that often outperform oral approaches on pharmacokinetic predictability and total cost
In 2022, the NHS published data comparing five different providers of the Digital Diabetes Prevention Programme
Provider guidance plays a significant role in maintaining results and preventing regrowth during this phase
She brings a broad portfolio of experience in NHS primary care, including general practice, NHS 111, and urgent care services